The North America Point of care diagnostic market was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 8.82% during the forecast period. The Point of care diagnostic (POC) tests refers to the diagnostic procedures, which are conducted outside the laboratories. POC diagnostic procedures are carried out by various POC diagnostic devices, which are used to test cholesterol and glucose levels, enzyme analysis, drugs of abuse testing, diagnosis of infectious diseases, and pregnancy testing.
NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2027
North America Point of Care Diagnostics Market by Mode of Prescription (Prescription Based Devices, Otc Based Devices) by End-user (Professional Diagnostic Centers, Research Laboratories, Home Care, Other End-user) by Product Type (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy and Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monitoring Kits, Urinalysis Testing Kits, Coagulation Monitoring Kits, Tumor/cancer Markers Testing Kits, Cholesterol Testing Trips, Drugs of Abuse Testing Kits, Fecal Occult Testing Kits, Other Product) by Geography.
The North America Point of care diagnostic market was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 8.82% during the forecast period.
The Point of care diagnostic (POC) tests refers to the diagnostic procedures, which are conducted outside the laboratories. POC diagnostic procedures are carried out by various POC diagnostic devices, which are used to test cholesterol and glucose levels, enzyme analysis, drugs of abuse testing, diagnosis of infectious diseases, and pregnancy testing.
The growing prevalence of chronic and infectious diseases, the rise in implementation of healthcare reforms and the rising demand for decentralized chronic and infectious disease testing are the main drivers for the growth of the point of care diagnostics market. The increase in healthcare spending also support the growth of the market. However, stringent government regulations for the approval of POC diagnostic devices is obstructing the growth of the market.
The growth in incidence and prevalence of diseases such as diabetes and cardiac disorders accompanied by the rise in the elderly population are some factors that majorly drive the POC diagnostic devices in North America. Increased awareness about innovative and advanced applications of POC diagnostic devices and well-established healthcare infrastructure also supports the growth of the point of care diagnostics market in North America. The United States and Canada is considered for market analysis.
The major companies operating in the market are Chembio Diagnost ICS Systems, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Biomérieux SA, Abbott, Cardinal Health Inc., Trivitron Healthcare, Becton Dickinson and Company, Gene POC, Siemens Healthineers, Ortho Clinical Diagnostics, Trinity Biotech, and Sight Diagnostics Ltd.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP-DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- INFECTIOUS DISEASE TESTING KIT IS THE FASTEST GROWING PRODUCT TYPE DURING THE FORECAST PERIOD
- PROFESSIONAL DIAGNOSTIC CENTERS ARE THE MAJOR END-USER IN POINT OF CARE MARKET
- PRESCRIPTION BASED DEVICES ARE THE FREQUENTLY USED MODE OF PRESCRIPTION
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- GROWING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES
- RISE IN THE IMPLEMENTATION OF HEALTHCARE REFORMS
- RISING DEMAND FOR DECENTRALIZED CHRONIC AND INFECTIOUS DISEASE TESTING
- MARKET RESTRAINTS
- STRINGENT REGULATION
- INSUFFICIENT REIMBURSEMENT POLICIES
- MARKET OPPORTUNITIES
- REDUCTION IN THE HEALTHCARE COST FACILITATES
- RISING INCIDENCES AND PREVALENCE RATES OF VARIOUS INFECTIOUS DISEASES
- GROWING NUMBER OF SMARTPHONE EMPOWERS PATIENTS TO MONITOR THEIR CLINICAL CONDITION ONLINE
- MARKET CHALLENGES
- CHALLENGES RELATED TO THE EXECUTION OF HIGHLY SENSITIVE DEVICES
- VARIATION IN TEST RESULTS
- DIFFICULTIES ASSOCIATED IN DATA MANAGEMENT
- MARKET BY MODE OF PRESCRIPTION
- PRESCRIPTION BASED DEVICES
- OTC BASED DEVICES
- MARKET BY END-USER
- PROFESSIONAL DIAGNOSTIC CENTERS
- RESEARCH LABORATORIES
- HOME CARE
- OTHER END-USER
- MARKET BY PRODUCT TYPE
- GLUCOSE MONITORING KITS
- INFECTIOUS DISEASES TESTING KITS
- PREGNANCY AND FERTILITY TESTING KITS
- HEMATOLOGY TESTING KITS
- CARDIOMETABOLIC MONITORING KITS
- URINALYSIS TESTING KITS
- COAGULATION MONITORING KITS
- TUMOR/CANCER MARKERS TESTING KITS
- CHOLESTEROL TESTING TRIPS
- DRUGS OF ABUSE TESTING KITS
- FECAL OCCULT TESTING KITS
- OTHER PRODUCT
- KEY ANALYTICS
- PORTER’S FIVE FORCES MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIERS
- THREAT OF COMPETITIVE RIVALRY
- POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL ANALYSIS
- REGULATORY FRAMEWORK
- PATENT ANALYSIS
- ETYMOLOGY OF POINT OF CARE MARKET
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCES MODEL
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- NORTH AMERICA
- COMPANY PROFILES
- ABBOTT
- BECTON DICKINSON AND COMPANY
- BIOMÉRIEUX SA
- BIO-RAD LABORATORIES, INC.
- CARDINAL HEALTH INC.
- CHEMBIO DIAGNOST ICS SYSTEMS, INC.
- DANAHER CORPORATION
- GENE POC
- HOFFMANN-LA ROCHE LTD.
- ORTHO CLINICAL DIAGNOSTICS
- QUEST DIAGNOSTICS INC.
- SIEMENS HEALTHINEERS
- SIGHT DIAGNOSTICS LTD.
- THERMO FISHER SCIENTIFIC INC.
- TRINITY BIOTECH
- TRIVITRON HEALTHCARE
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
TABLE 2Â Â Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY MODE OF PRESCRIPTION 2019-2027 ($ MILLION)
TABLE 3Â Â Â Â Â Â Â NORTH AMERICA PRESCRIPTION BASED DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 4Â Â Â Â Â Â Â NORTH AMERICA OTC BASED DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 5Â Â Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 6Â Â Â Â Â Â Â NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS MARKET 2019-2027 ($ MILLION)
TABLE 7Â Â Â Â Â Â Â NORTH AMERICA RESEARCH LABORATORIES MARKET 2019-2027 ($ MILLION)
TABLE 8Â Â Â Â Â Â Â NORTH AMERICA HOME CARE MARKET 2019-2027 ($ MILLION)
TABLE 9Â Â Â Â Â Â Â NORTH AMERICA OTHER END-USER MARKET 2019-2027 ($ MILLION)
TABLE 10Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY PRODUCT TYPE 2019-2027 ($ MILLION)
TABLE 11Â Â Â Â Â NORTH AMERICA GLUCOSE MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 12Â Â Â Â Â NORTH AMERICA INFECTIOUS DISEASES TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 13Â Â Â Â Â NORTH AMERICA PREGNANCY AND FERTILITY TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 14Â Â Â Â Â NORTH AMERICA HEMATOLOGY TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 15Â Â Â Â Â NORTH AMERICA CARDIOMETABOLIC MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 16Â Â Â Â Â NORTH AMERICA URINALYSIS TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 17Â Â Â Â Â NORTH AMERICA COAGULATION MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 18Â Â Â Â Â NORTH AMERICA TUMOR/CANCER MARKERS TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 19Â Â Â Â Â NORTH AMERICA CHOLESTEROL TESTING TRIPS MARKET 2019-2027 ($ MILLION)
TABLE 20Â Â Â Â Â NORTH AMERICA DRUGS OF ABUSE TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 21Â Â Â Â Â NORTH AMERICA FECAL OCCULT TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 22Â Â Â Â Â NORTH AMERICA OTHER PRODUCT MARKET 2019-2027 ($ MILLION)
TABLE 23Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
LIST OF FIGURES
FIGURE 1Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 2Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET SHARE BY MODE OF PRESCRIPTION 2018 & 2027 (%)
FIGURE 3Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY PRESCRIPTION BASED DEVICES 2019-2027 ($ MILLION)
FIGURE 4Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY OTC BASED DEVICES 2019-2027 ($ MILLION)
FIGURE 5Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 6Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY PROFESSIONAL DIAGNOSTIC CENTERS 2019-2027 ($ MILLION)
FIGURE 7Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY RESEARCH LABORATORIES 2019-2027 ($ MILLION)
FIGURE 8Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY HOME CARE 2019-2027 ($ MILLION)
FIGURE 9Â Â Â Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 10Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET SHARE BY PRODUCT TYPE 2018 & 2027 (%)
FIGURE 11Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY GLUCOSE MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 12Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY INFECTIOUS DISEASES TESTING KITS 2019-2027 ($ MILLION)
FIGURE 13Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY PREGNANCY AND FERTILITY TESTING KITS 2019-2027 ($ MILLION)
FIGURE 14Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY HEMATOLOGY TESTING KITS 2019-2027 ($ MILLION)
FIGURE 15Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY CARDIOMETABOLIC MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 16Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY URINALYSIS TESTING KITS 2019-2027 ($ MILLION)
FIGURE 17Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY COAGULATION MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 18Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY TUMOR/CANCER MARKERS TESTING KITS 2019-2027 ($ MILLION)
FIGURE 19Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY CHOLESTEROL TESTING TRIPS 2019-2027 ($ MILLION)
FIGURE 20Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY DRUGS OF ABUSE TESTING KITS 2019-2027 ($ MILLION)
FIGURE 21Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY FECAL OCCULT TESTING KITS 2019-2027 ($ MILLION)
FIGURE 22Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY OTHER PRODUCT 2019-2027 ($ MILLION)
FIGURE 23  PORTER’S FIVE FORCE MODEL
FIGURE 24Â Â NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 25Â Â THE UNITED STATES POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 26Â Â CANADA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET BY MODE OF PRESCRIPTION
- PRESCRIPTION BASED DEVICES
- OTC BASED DEVICES
- MARKET BY END-USER
- PROFESSIONAL DIAGNOSTIC CENTERS
- RESEARCH LABORATORIES
- HOME CARE
- OTHER END-USER
- MARKET BY PRODUCT TYPE
- GLUCOSE MONITORING KITS
- INFECTIOUS DISEASES TESTING KITS
- PREGNANCY AND FERTILITY TESTING KITS
- HEMATOLOGY TESTING KITS
- CARDIOMETABOLIC MONITORING KITS
- URINALYSIS TESTING KITS
- COAGULATION MONITORING KITS
- TUMOR/CANCER MARKERS TESTING KITS
- CHOLESTEROL TESTING TRIPS
- DRUGS OF ABUSE TESTING KITS
- FECAL OCCULT TESTING KITS
- OTHER PRODUCT
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.